Ellsworth Advisors LLC Buys New Position in Guardian Pharmacy Services, Inc. $GRDN

Ellsworth Advisors LLC bought a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 27,990 shares of the company’s stock, valued at approximately $1,141,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in GRDN. State of Alaska Department of Revenue increased its position in shares of Guardian Pharmacy Services by 105.9% during the 3rd quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company’s stock valued at $97,000 after purchasing an additional 1,229 shares during the period. Arizona State Retirement System lifted its holdings in shares of Guardian Pharmacy Services by 53.0% in the second quarter. Arizona State Retirement System now owns 8,393 shares of the company’s stock valued at $351,000 after buying an additional 2,907 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Guardian Pharmacy Services in the second quarter valued at $335,000. Round Rock Advisors LLC lifted its holdings in shares of Guardian Pharmacy Services by 57.0% in the second quarter. Round Rock Advisors LLC now owns 18,524 shares of the company’s stock valued at $776,000 after buying an additional 6,729 shares during the period. Finally, Braun Stacey Associates Inc. bought a new position in Guardian Pharmacy Services during the second quarter valued at about $14,234,000.

Analysts Set New Price Targets

A number of research firms recently issued reports on GRDN. Oppenheimer lifted their target price on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a report on Friday, August 7th. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. Truist Financial upped their price target on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a report on Monday, September 21st. KeyCorp initiated coverage on shares of Guardian Pharmacy Services in a report on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 price target for the company. Finally, Wall Street Zen lowered shares of Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research report on Saturday, September 19th. Nine research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $45.57.

Guardian Pharmacy Services Stock Performance

Guardian Pharmacy Services stock opened at $39.69 on Friday. The firm has a market cap of $1.98 billion, a price-to-earnings ratio of 38.54, a price-to-earnings-growth ratio of 2.12 and a beta of 0.03. Guardian Pharmacy Services, Inc. has a 1 year low of $23.72 and a 1 year high of $48.33. The firm’s 50 day moving average price is $40.91 and its two-hundred day moving average price is $39.87.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. The company had revenue of $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. As a group, equities analysts predict that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current fiscal year.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc (NYSE: GRDN) is a healthcare services company that provides pharmacy services to residents of long-term care and other institutional healthcare settings. Its customers include assisted living communities, skilled nursing facilities, behavioral health centers and communities serving individuals with developmental disabilities.

The company’s services include prescription dispensing, medication packaging and delivery, medication management, pharmacy consulting and clinical support.